| NAME |
ROPEGINTERFERON ALFA-2B-NJFT 500MCG/ML INJ,SYRINGE,1ML |
| VA GENERIC NAME |
ROPEGINTERFERON |
| DOSAGE FORM |
INJ,SOLN |
| FDA MED GUIDE |
Ropeginterferon-alfa-2b-njft_(Besremi)_(2021).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| PRIMARY EPA CODE |
D017 |
| WASTE SORT CODE |
BKC |
| DOT SHIPPING CODE |
Flammable liquids, n.o.s.
|
| ACTIVE INGREDIENTS |
|
| STRENGTH |
500 |
| UNITS |
MCG/ML |
| NATIONAL FORMULARY NAME |
ROPEGINTERFERON INJ,SOLN |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
No Possible Dosages |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2021-12-02 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
BESREMI 500MCG/ML INJ SYRINGE 1ML |
| VA PRODUCT IDENTIFIER |
B0925 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
SYR |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4041001 |
| EFFECTIVE DATE/TIME |
-
- 2021-12-02 00:00:00
- STATUS: ACTIVE
|
